Abstract
Background and aim
Endoscopic mucosal resection (EMR) has become the standard treatment for early oesophageal neoplasia. The mucosal defect caused by EMR usually takes several weeks to heal. Despite guidelines on high-risk endoscopic procedures in patients on anticoagulation, evidence is lacking whether EMR is safe in such patients. We investigated the immediate and delayed bleeding risk in patients undergoing diagnostic or therapeutic oesophageal EMR comparing patients requiring warfarin anticoagulation with a control group.
Methods
Warfarin was stopped 5 days before the planned EMR and restarted on the evening following the procedure. Patients with high-risk conditions, such as recent pulmonary thromboemboli, received bridging with low molecular weight heparin. All EMRs were performed when the INR was <1.5. Bleeding events on the day of the EMR and within 3 months post-procedure were documented.
Results
One hundred and seventeen consecutive patients with early oesophageal neoplasia were included. Sixty-eight EMRs were performed in 15 patients requiring anticoagulation. One patient on warfarin was readmitted 10 days after EMR with haematemesis and melaena. Out of 400 EMRs in 102 controls, 26 immediate bleeding events occurred requiring endoscopic intervention. One delayed bleeding event (melaena) occurred in the control group. The number of bleeding events did not differ between groups [p = 0.99; odds ratio 1.01 (0.30–3.44)], neither for acute (p = 0.76) nor delayed bleeding (p = 0.24).
Conclusion
EMR of early oesophageal neoplasia can be safely performed in patients requiring anticoagulation when warfarin is discontinued 5 days before the endoscopic intervention and reinstituted on the evening of the procedure day.
Similar content being viewed by others
References
Matsumoto M, Fukunaga S, Saito Y, Matsuda T, Nakajima T, Sakamoto T, Tamai N, Kikuchi T (2012) Risk factors for delayed bleeding after endoscopic resection for large colorectal tumors. Jpn J Clin Oncol 42:1028–1034. doi:10.1093/jjco/hys131
Ono S, Fujishiro M, Hirano K, Niimi K, Goto O, Kodashima S, Yamamichi N, Koike K (2009) Retrospective analysis on the management of anticoagulants and antiplatelet agents for scheduled endoscopy. J Gastroenterol 44:1185–1189. doi:10.1007/s00535-009-0127-6
Kakushima N, Fujishiro M, Kodashima S, Kobayashi K, Tateishi A, Iguchi M, Imagawa A, Motoi T, Yahagi N, Omata M (2006) Histopathologic characteristics of gastric ulcers created by endoscopic submucosal dissection. Endoscopy 38:412–415. doi:10.1055/s-2006-925166
Honda M, Nakamura T, Hori Y, Shionoya Y, Nakada A, Sato T, Yamamoto K, Kobayashi T, Shimada H, Kida N, Hashimoto A, Hashimoto Y (2010) Process of healing of mucosal defects in the esophagus after endoscopic mucosal resection: histological evaluation in a dog model. Endoscopy 42:1092–1095. doi:10.1055/s-0030-1255741
Davy J-M, Roubille F, Tri Cung T, Massin F, Crausac F, Raczka F, Pasquié J-L (2010) Atrial fibrillation in 2010: an increasing morbidity and mortality burden. Ann Cardiol Angeiol (Paris) 59(Suppl 1):S4–13. doi:10.1016/S0003-3928(10)70002-0
Blacker DJ, Wijdicks EFM, McClelland RL (2003) Stroke risk in anticoagulated patients with atrial fibrillation undergoing endoscopy. Neurology 61:964–968
Gerson LB, Michaels L, Ullah N, Gage B, Williams L (2010) Adverse events associated with anticoagulation therapy in the periendoscopic period. Gastrointest Endosc 71(1211–1217):e2. doi:10.1016/j.gie.2009.12.054
Veitch AM, Baglin TP, Gershlick AH, Harnden SM, Tighe R, Cairns S, British Society of Gastroenterology, British Committee for Standards in Haematology, British Cardiovascular Intervention Society (2008) Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures. Gut 57:1322–1329. doi:10.1136/gut.2007.142497
Eisen GM, Baron TH, Dominitz JA, Faigel DO, Goldstein JL, Johanson JF, Mallery JS, Raddawi HM, Vargo JJ, Waring JP, Fanelli RD, Wheeler-Harbough J, American Society for Gastrointestinal Endoscopy (2002) Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastrointest Endosc 55:775–779
ASGE Standards of Practice Committee, Anderson MA, Ben-Menachem T, Gan SI, Appalaneni V, Banerjee S, Cash BD, Fisher L, Harrison ME, Fanelli RD, Fukami N, Ikenberry SO, Jain R, Khan K, Krinsky ML, Lichtenstein DR, Maple JT, Shen B, Strohmeyer L, Baron T, Dominitz JA (2009) Management of antithrombotic agents for endoscopic procedures. Gastrointest Endosc 70:1060–1070. doi:10.1016/j.gie.2009.09.040
Boustière C, Veitch A, Vanbiervliet G, Bulois P, Deprez P, Laquiere A, Laugier R, Lesur G, Mosler P, Nalet B, Napoleon B, Rembacken B, Ajzenberg N, Collet JP, Baron T, Dumonceau J-M, European Society of Gastrointestinal Endoscopy (2011) Endoscopy and antiplatelet agents. European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 43:445–461. doi:10.1055/s-0030-1256317
Witt DM, Delate T, McCool KH, Dowd MB, Clark NP, Crowther MA, Garcia DA, Ageno W, Dentali F, Hylek EM, Rector WG (2009) Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy. J Thromb Haemost 7:1982–1989. doi:10.1111/j.1538-7836.2009.03598.x
Hui AJ, Wong RMY, Ching JYL, Hung LCT, Chung SCS, Sung JJY (2004) Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: analysis of 1657 cases. Gastrointest Endosc 59:44–48
Sawhney MS, Salfiti N, Nelson DB, Lederle FA, Bond JH (2008) Risk factors for severe delayed postpolypectomy bleeding. Endoscopy 40:115–119. doi:10.1055/s-2007-966959
Alvarez Herrero L, Pouw RE, van Vilsteren FGI, ten Kate FJW, Visser M, Seldenrijk CA, van Berge Henegouwen MI, Weusten BLAM, Bergman JJGHM (2011) Safety and efficacy of multiband mucosectomy in 1060 resections in Barrett’s esophagus. Endoscopy 43:177–183. doi:10.1055/s-0030-1256095
May A, Gossner L, Pech O, Fritz A, Günter E, Mayer G, Müller H, Seitz G, Vieth M, Stolte M, Ell C (2002) Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett’s oesophagus: acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol 14:1085–1091
Peters FP, Kara MA, Curvers WL, Rosmolen WD, Fockens P, Krishnadath KK, ten Kate FJW, Bergman JJGHM (2007) Multiband mucosectomy for endoscopic resection of Barrett’s esophagus: feasibility study with matched historical controls. Eur J Gastroenterol Hepatol 19:311–315. doi:10.1097/MEG.0b013e328080ca90
Giovannini M, Bories E, Pesenti C, Moutardier V, Monges G, Danisi C, Lelong B, Delpero JR (2004) Circumferential endoscopic mucosal resection in Barrett’s esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients. Endoscopy 36:782–787. doi:10.1055/s-2004-825813
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Said Al-Mammari, Richard Owen, John Findlay, Andreas Koutsoumpas, Richard Gillies, Robert Marshall, Adam A. Bailey, Nick Maynard, Bruno Sgromo and Barbara Braden have no conflict of interest or financial ties to disclose.
Rights and permissions
About this article
Cite this article
Al-Mammari, S., Owen, R., Findlay, J. et al. Endoscopic mucosal resection of early oesophageal neoplasia in patients requiring anticoagulation: is it safe?. Surg Endosc 30, 2390–2395 (2016). https://doi.org/10.1007/s00464-015-4489-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-015-4489-y